AN 0128
Alternative Names: AN-0128; Borinic acid ester - Pfizer; CRM-0005; ONT-0001Latest Information Update: 29 Mar 2011
At a glance
- Originator Anacor Pharmaceuticals
- Class Antibacterials; Organic boron compounds; Pyridines; Skin disorder therapies; Small molecules
- Mechanism of Action P38 mitogen-activated protein kinase inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Acne; Atopic dermatitis; Psoriasis; Rosacea; Staphylococcal infections
Most Recent Events
- 29 Mar 2011 No development reported - Phase-I/II for Psoriasis in USA (Topical)
- 29 Mar 2011 No development reported - Phase-II for Acne in USA (Topical)
- 29 Mar 2011 No development reported - Phase-II for Atopic dermatitis in USA (Topical)